therapy for adults who are not allergic to penicillin (DeCastro, Mims, & Hueston, 2014). The prescribed drug belongs to the class of penicillin-like antibiotics, which works by discontinuing
COMMON COLD TREATMENT CASE STUDY 4 the growth of bacteria. Amoxicillin binds to penicillin-binding proteins, thus inhibiting final transpeptidation step of peptidoglycan synthesis in bacterial cell walls; the addition of clavulanate inhibits beta-lactamase-producing bacteria, allowing amoxicillin extended the spectrum of action. It is a semisynthetic antibiotic with a broad range of bactericidal activity, covering both gram-negative and gram-positive microorganisms. His dose of amoxicillin- clavulanate is 875 mg/125 mg orally twice daily for seven days. It comes in different oral forms such as tablets, chewable tablets, extended-release tablets, and suspension. The half-life is 1-1.5 hours. The drug is metabolized in liver and excreted in urine. As for the contraindications, the drug should not be used by patients are hypersensitive to penicillin (Woo & Robinson, 2015). It is also contraindicated in patients with carbapenem hypersensitivity, cephalosporin hypersensitivity, eczema, urticaria, and asthma. It needs to be used with caution in those patients with pre-existing hepatic disease and monitor liver function during therapy (amoxicillin/clavulanate potassium, 2018). Some of the adverse drug reactions associated with this medication include serum sickness, vasculitis, angioedema, seizures, insomnia, dizziness, lightheadedness, headaches, nausea, vomiting, gas, diarrhea, and dizziness among other effects. Currently, there’s no black box warning for amoxicillin/clavulanate. 4.Would this treatment vary if Mr. JD was a ten-year-old 78 lb child? Include the classof the medication, mechanism of action, dosing, route, the half-life; how it is metabolized in and eliminated from the body; and contraindications and black box warnings
You've reached the end of your free preview.
Want to read all 8 pages?
- Fall '17
- Common cold, nasal congestion, Sinusitis, Advanced Pharmacology, Treatment Case Study, NSG6005, SUO PHARM, Nursing6005, Fnp6005, COLD TREATMENT CASE, COMMON COLD TREATMENT